Tics and BFRBs may seem alike, but knowing the difference can shape treatment and improve outcomes. Here's what you need to ...

The technique used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other ...

During a live event, Pedro C. Barata, MD, MSc, discussed the case of a patient with advanced clear cell renal cell carcinoma who requires second-line therapy.

This is a completely new paradigm of treatment for depression, and it actually works,” Dr. Aaron Tendler told The Post.

This is the first exosome-based therapy in Korea to enter clinical trials, marking a major milestone in the country's biopharmaceutical landscape. S&E bio developed SNE-101 using a proprietary 3D ...

XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced positive interim results from its first-in ...

Dallas opted to bolster its offensive line with its first-round pick in the 2025 NFL draft, taking Alabama offensive guard Tyler Booker. It seems like a trend as Dallas notably took linemen Tyler ...

Dan is undergoing surgeries and therapy in Central Florida after suffering severe leg ... and also works at the Eau Gallie Veterinary Hospital. She was one of the first doctors who saw the pup when he ...

Because it may cause side effects, it’s generally not a first-line treatment for COPD therapy. Treatment can ease symptoms, prevent complications, and generally slow disease progression.

Norwegian Cruise Line Holdings Ltd. (NCLH), a leading global cruise operator, has opened its first medical clinic in the Philippines to serve its Filipino seafarers. The NCLH Medical Clinic and ...

Since 2018, anti-PD-1 monoclonal antibodies have been approved for the second-line or later treatment of advanced melanoma in China and are widely used clinically. However, the first-line standard ...

The approval of the first-line CLL/SLL treatment will enable orelabrutinib to benefit an even broader population of lymphoma patients. Orelabrutinib has been approved for the treatment of three ...